Health Matters

Tag: TLD

  • AIDS Drug Tender Faces Health Department Pushback

    The Health Department has defended its R15.5bn AIDS drug tender against a legal challenge from pharmaceutical manufacturer Cipla. The department argues that officials followed a fair and rational process when awarding contracts to supply key HIV medicines. The dispute centres on contracts that took effect on 1 December 2025. They cover the daily treatment used by most HIV patients. Cipla,…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in

  • HIV ARV Tender Crisis Triggers Parliamentary Scrutiny

    Health Minister Aaron Motsoaledi faces urgent questions in Parliament after two companies holding major government contracts to supply HIV medicines entered business rescue. The concern is immediate and practical. Any disruption to antiretroviral (ARV) supply can lead to missed doses. That raises the risk of treatment failure and drug resistance. South Africa carries the world’s biggest HIV burden. An estimated…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in

  • AIDS Drug Tender: Pressure as Suppliers Enter Business Rescue

    Two pharmaceutical companies awarded a share of South Africa’s latest Aids drug tender are in business rescue and have struggled to consistently supply the state. Avacare Health subsidiaries Barrs and Innovata each won portions of the core contract to supply TLD. Most HIV patients use this three-in-one antiretroviral pill. Both entities entered business rescue in December. Therefore, this raised concerns…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in